University of Queensland researchers report they have discovered evidence of neurogenesis in the amygdala. Researchers say their findings could help develop new avenues of treatment for fear processing disorders.
A new study provides further evidence for immune system activation during pregnancy and disruptions in brain development. Many adult diseases, researchers say, may originate during fetal development.
A new study into human and plant cell apoptosis could provide new avenues for the development of treatments for neurodegenerative diseases, and help develop disease-resistant plants.
Six potential drug candidates have been identified as candidates to treat COVID-19 infections. The drugs, which have previously been subjected to clinical trials for treating a range of conditions, from arthritis to cancer, target Mpro, the main SARS-CoV-2 enzyme.
Women who experience depression have an increased risk of developing multiple chronic diseases, such as diabetes and hypertension.
NAPRT1, a gene that encodes an enzyme involved in vitamin B3 metabolism, may be a risk factor for schizophrenia. Knocking out the gene in zebrafish models, researchers discovered brain development became impaired. Without NAPRT1, the fish brains failed to divide symmetrically, which is significant as defects in the corpus callosum have been identified in those with schizophrenia.
Study reveals personality disorders and schizophrenia are the most debilitating mental illnesses to live with.
The SARM1 protein triggers a cascade of degeneration associated with Alzheimer's, Parkinson's, and other neurodegenerative diseases. Researchers hope new drugs can be developed to directly target this protein to fight neurodegeneration.